Senior insider sale
Head of R&D at NEUMORA THERAPEUTICS, INC. — senior position signals high conviction
$9.4K
5.61K shares
What this filing means
LENZ ROBERT A. plans to sell 5.61K shares of NEUMORA THERAPEUTICS, INC. valued at approximately $9.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2025ACC: 0001964306-25-000078
Officer· Head of R&D
Since Sep 2023
5.61K
Shares to sell
$9.4K
Approx. market value
5.61K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
2/14/2025
5.61KTotal acquired5.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 5.61K | — |
| Total | 5.61K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.61K
Market value
$9.4K
2/18/2025
Total
Units
5.61K
Value
$9.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/18/2025 | 5.61K | $9.4K | NASDAQ | Planned |
| Total | 5.61K | $9.4K | ||